Stallion India Fluorochemicals Ltd

Neomile Corporate Advisory Ltd and Neomile Growth Fund - Series I, through Neomile Asset Managers Pvt. Ltd., have disclosed a sale of shares in Stallion India Fluorochemicals Ltd. The transaction, conducted via open market operations between June 1st and June 4th, 2026, resulted in a reduction of their shareholding. The exact percentage change and final holding details are provided in the disclosure, adhering to SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. The acquirers are not part of the promoter group.

Stallion India Fluorochemicals Ltd's monitoring agency, CARE Ratings, reported a deviation in the utilization of IPO proceeds for the quarter ended March 31, 2026. The company exceeded the specified issue expenses by ₹3.99 crore, with actual spending reaching ₹15.99 crore against a prospectus allocation of ₹11.99 crore, constituting a material deviation. The report also highlights discrepancies in data submission by the company regarding issue expenses under working capital.

Stallion India Fluorochemicals Ltd (SIFL) reported strong FY26 results, driven by strategic preparedness and operational resilience. Total revenue increased by 14.40% YoY to ₹434.12 crores. EBITDA grew by 23.34% to ₹61.35 crores, and PAT increased by 35.61% to ₹43.84 crores. The company proactively strengthened its sourcing network and inventory planning to navigate global supply-chain volatility. The R-32 manufacturing facility at Bhilwara is on track for commencement by October 2026. SIFL anticipates a revenue CAGR of 30–35% over the next 3 years with margin improvements of 3–4%.

Stallion India Fluorochemicals Ltd's board approved the audited financial results for the quarter and year ended March 31, 2026, with an unmodified audit report. Ms. Swati Ghosh was appointed as a Non-Executive Independent Director, effective May 13, 2026, subject to shareholder approval. A postal ballot notice was approved to seek shareholder consent for Ms. Ghosh's appointment, with a cut-off date of May 15, 2026, for determining eligible members for e-voting.

Stallion India Fluorochemicals Ltd has scheduled a Board of Directors meeting on May 13, 2026, to consider and approve the Annual Audited Financial Statements for the financial year ended March 31, 2026, along with the Auditors' Reports.

Stallion India Fluorochemicals Ltd responded to stock exchange queries regarding recent share price movement, confirming that all material information has been duly disclosed in a timely manner, adhering to SEBI Listing Regulations. The company stated there is no unpublished price-sensitive information, pending announcements, or corporate actions that could explain the price or volume behavior of its securities. Previous disclosures include land allotment and environmental clearance for its R-32 manufacturing plant in Bhilwara, an MoU with the Government of Rajasthan for the plant, and a strategic partnership with Sharjah Oxygen Company for sourcing Liquid Helium. The company concluded that any movement in its share price is purely market-driven.

Shri Gautam Lath, an Independent Director of Stallion India Fluorochemicals Ltd, has tendered his resignation with effect from April 20, 2026. The reason cited for his departure is "increasing professional commitments." Consequently, he has also stepped down from all committees of the company where he served as a Chairman or Member. The company has confirmed that Shri Lath stated there are no other material reasons for his resignation beyond those provided in his letter.

Stallion India Fluorochemicals Ltd has announced the appointment of M/s. Himani R. Patel & Associates, Chartered Accountants (FRN: 145894W), as its Internal Auditor. This appointment, based on the Audit Committee's recommendation, was approved during a Board Meeting held on April 20, 2026. The firm will serve for the Financial Year 2026-27 and is engaged in providing direct tax, indirect tax, audit, and accounting services. The company confirmed that the firm has no relationship with its directors.

Stallion India Fluorochemicals Ltd announced the outcome of its Rights Issue Committee of Directors meeting held on April 20, 2026. Key decisions included noting the resignation of Independent Director Mr. Gautam Lath and approving a variation in the objects and terms of utilization of IPO proceeds. This variation, which involves re-allocating unutilized IPO funds, is subject to shareholder approval via a postal ballot. The company has set April 24, 2026, as the cut-off date for determining eligible members to receive the postal ballot notice and cast their votes through remote e-voting.

Stallion India Fluorochemicals Ltd has announced the closure of the trading window for dealing in the securities of the company for all designated persons and their immediate relatives. This closure is in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's Prohibition of Insider Trading Policy. The closure will be effective from April 01, 2026, until 48 hours after the declaration of the Audited Financial results for the quarter and financial year ending March 31, 2026. The date of the Board Meeting for the declaration of these results will be intimated in due course.